210 related articles for article (PubMed ID: 23503754)
21. Radiosensitization by bromodeoxyuridine and hyperthermia: analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines.
Franken NA; Van Bree C; Veltmaat MA; Rodermond HM; Haveman J; Barendsen GW
J Radiat Res; 2001 Jun; 42(2):179-90. PubMed ID: 11599884
[TBL] [Abstract][Full Text] [Related]
22. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
23. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
Malaise EP; Lambin P; Joiner MC
Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
[TBL] [Abstract][Full Text] [Related]
24. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
25. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
Gay HA; Jin JY; Chang AJ; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
[TBL] [Abstract][Full Text] [Related]
26. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.
Ohri N; Dicker AP; Lawrence YR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):385-93. PubMed ID: 22265460
[TBL] [Abstract][Full Text] [Related]
27. The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
Wennberg B; Lax I
Acta Oncol; 2013 Jun; 52(5):902-9. PubMed ID: 23327339
[TBL] [Abstract][Full Text] [Related]
28. Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review).
Barendsen GW; Van Bree C; Franken NA
Int J Oncol; 2001 Aug; 19(2):247-56. PubMed ID: 11445835
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic formulation of a lineal-quadratic-linear (LQL) model: split-dose experiments and exponentially decaying sources.
Guerrero M; Carlone M
Med Phys; 2010 Aug; 37(8):4173-81. PubMed ID: 20879577
[TBL] [Abstract][Full Text] [Related]
30. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
31. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
Carlson DJ; Stewart RD; Semenenko VA
Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
[TBL] [Abstract][Full Text] [Related]
32. An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor.
Qi XS; Schultz CJ; Li XA
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1570-80. PubMed ID: 16580506
[TBL] [Abstract][Full Text] [Related]
33. A challenge to traditional radiation oncology.
Fowler JF; Tomé WA; Fenwick JD; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
[TBL] [Abstract][Full Text] [Related]
34. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
35. Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines.
van den Aardweg GJ; Naus NC; Verhoeven AC; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2561-5. PubMed ID: 12147585
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
37. Is α/β for breast cancer really low?
Qi XS; White J; Li XA
Radiother Oncol; 2011 Aug; 100(2):282-8. PubMed ID: 21367477
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the dose- and time-dependence of the induction of different types of cell death in a small‑cell lung cancer cell line: Implementation of the repairable-conditionally repairable model.
Makris N; Edgren M; Mavroidis P; Lind BK
Int J Oncol; 2013 Jun; 42(6):2019-27. PubMed ID: 23588899
[TBL] [Abstract][Full Text] [Related]
39. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
[TBL] [Abstract][Full Text] [Related]
40. Comparison of fractionation schedules in the large heterogeneity limit.
Guerrero M
Med Phys; 2009 Apr; 36(4):1384-8. PubMed ID: 19472645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
